4D Molecular Therapeutics saw the highest growth of 0.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of 4D Molecular Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
4D Molecular Therapeutics has been focused on protecting inventions in European Patent Office(EPO) with one publication in Q2 2024
The United States(US), and European Patent Office(EPO) patent Office are among the top ten patent offices where 4D Molecular Therapeutics is filings its patents..
University of Pennsylvania could be the strongest competitor for 4D Molecular Therapeutics
Patents related to rare diseases lead 4D Molecular Therapeutics's portfolio
4D Molecular Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Telangiectasis related patents lead 4D Molecular Therapeutics portfolio followed by diabetic macular edema, and diabetic retinopathy
4D Molecular Therapeutics has highest number of patents in telangiectasis followed by diabetic macular edema, diabetic retinopathy, choroidal disease, and choroidal neovascularization.
For comprehensive analysis of 4D Molecular Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
